Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186,164,820
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
88,251,337
-
Shares change
-
+1,228,484
-
Total reported value, excl. options
-
$2,102,174,977
-
Value change
-
+$32,658,345
-
Put/Call ratio
-
32%
-
Number of buys
-
70
-
Number of sells
-
-57
-
Price
-
$23.82
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q4 2022
159 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q4 2022.
Revolution Medicines, Inc. - Common Stock (RVMD) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 88,251,337 shares
of 186,164,820 outstanding shares and own 47% of the company stock.
Largest 10 shareholders include WELLINGTON MANAGEMENT GROUP LLP (8,873,974 shares), VANGUARD GROUP INC (7,561,910 shares), BlackRock Inc. (6,575,946 shares), Bellevue Group AG (4,855,162 shares), Column Group LLC (4,577,840 shares), EcoR1 Capital, LLC (4,458,731 shares), Nextech Invest Ltd. (4,189,529 shares), Boxer Capital, LLC (3,984,264 shares), STATE STREET CORP (3,781,011 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (3,680,042 shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.